PIM
TEVA icon

Partner Investment Management’s Teva Pharmaceuticals TEVA Stock Holding History

Partner Investment Management’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q1 		– Sell
-37,993
Closed -$2.49M – 94
2015
Q4 		$2.49M Buy
37,993
+7,801
+26% +$482K 4.18% 4
2015
Q3 		$1.71M Buy
30,192
+5,051
+20% +$328K 2.58% 11
2015
Q2 		$1.49M Buy
25,141
+9,832
+64% +$607K 2.09% 14
2015
Q1 		$954K Sell
15,309
-102,322
-87% -$5.95M 1.44% 25
2014
Q4 		$6.76M Buy
117,631
+17,192
+17% +$958K 2.76% 9
2014
Q3 		$5.4M Sell
100,439
-238,646
-70% -$12.6M 1.97% 23
2014
Q2 		$17.8M Buy
339,085
+28,153
+9% +$1.44M 3.56% 10
2014
Q1 		$16.4M Buy
+310,932
New +$14.4M 3.03% 9

Other funds holding TEVA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
PC
Paulson & Co New York $3.11B AUM 94.93% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $653B AUM 32.41% 1-Year Est. Return
WRF
Waddell & Reed Financial Overland Park, Kansas $48.6B AUM 84.78% 1-Year Est. Return
Lazard Asset Management
Lazard Asset Management New York $60.7B AUM 22.47% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return